These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9715413)

  • 1. From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament.
    Makino I; Tanaka H
    J Gastroenterol Hepatol; 1998 Jun; 13(6):659-64. PubMed ID: 9715413
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alternative treatment to interferon therapy in chronic viral hepatitis].
    Salmerón Escobar FJ
    Gastroenterol Hepatol; 1995 Oct; 18(8):430-6. PubMed ID: 7584785
    [No Abstract]   [Full Text] [Related]  

  • 3. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
    Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV
    Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
    Serfaty L; Poupon R
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in treatment of chronic toxic hepatitis by ursodeoxicholic acid].
    Agzamova GS
    Med Tr Prom Ekol; 2001; (1):39-42. PubMed ID: 11221110
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
    Makino I
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
    [No Abstract]   [Full Text] [Related]  

  • 8. Ursodeoxycholic acid after liver transplantation: does conjugation with taurine make the difference?
    Beuers U
    Ital J Gastroenterol Hepatol; 1999; 31(6):469-71. PubMed ID: 10575564
    [No Abstract]   [Full Text] [Related]  

  • 9. [New aspects of pharmacological effects of ursodeoxycholic acid].
    Radchenko VG; Seliverstov PV; Sitkin SI
    Eksp Klin Gastroenterol; 2014; (8):4-10. PubMed ID: 25911905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid in the treatment of liver diseases.
    Saksena S; Tandon RK
    Postgrad Med J; 1997 Feb; 73(856):75-80. PubMed ID: 9122101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatobiliary lesions in Crohn's disease and conservative methods of treatment].
    Grigor'eva GA; Meshalkina NIu
    Eksp Klin Gastroenterol; 2013; (6):3-6. PubMed ID: 24772851
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.
    Matsuda Y; Inada M; Maeda H; Matsuyama T
    Intern Med; 2002 Oct; 41(10):774-9. PubMed ID: 12412994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
    Trauner M; Graziadei IW
    Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic inflammatory diseases of the biliary tract in children with the new choleretic drug Stachyren].
    Shmorgun SS; Zinchenko TV; Kuz'menko IA
    Farm Zh; 1971; 26(6):48-50. PubMed ID: 5150543
    [No Abstract]   [Full Text] [Related]  

  • 15. Ursodeoxycholic acid therapy in hepatobiliary disease.
    Kowdley KV
    Am J Med; 2000 Apr; 108(6):481-6. PubMed ID: 10781781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new choleretic mixture (hydro- and cytocholeretic)].
    Boisson J; Albot G
    Actual Hepatogastroenterol (Paris); 1966; 2(4):XXIX-XXXI. PubMed ID: 5983695
    [No Abstract]   [Full Text] [Related]  

  • 17. Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?
    Gluud C; Christensen E
    J Hepatol; 2001 May; 34(5):787-8. PubMed ID: 11434634
    [No Abstract]   [Full Text] [Related]  

  • 18. Ursodeoxycholic acid for primary biliary cirrhosis.
    Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
    Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
    [No Abstract]   [Full Text] [Related]  

  • 19. Examining the increased IgM production and ursodeoxycholic acid treatment in PBC.
    Lazaridis KN; Larusso NF
    Gastroenterology; 2005 Feb; 128(2):498-500. PubMed ID: 15685560
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.